From the Food and Drug Administration.
Nightingale
S L
SL
D002908:Chronic Disease; D004033:Diet Fads; D004043:Dietary Fiber / Q000009:adverse effects*; D004338:Drug Combinations / Q000627:therapeutic use; D004940:Esophageal Stenosis / Q000139:chemically induced; D005233:Fatty Alcohols / Q000627:therapeutic use; D005283:Fentanyl / Q000008:administration & dosage / Q000627:therapeutic use*; D005685:Galactans / Q000009:adverse effects*; D006801:Humans; D007230:Infant, Low Birth Weight; D007231:Infant, Newborn; D008351:Mannans / Q000009:adverse effects*; D010146:Pain / Q000188:drug therapy; D010767:Phosphorylcholine; D053149:Plant Gums; D011092:Polyethylene Glycols / Q000627:therapeutic use; D011663:Pulmonary Surfactants / Q000627:therapeutic use; D012127:Respiratory Distress Syndrome, Newborn / Q000628:therapy*; D014481:United States; D014486:United States Food and Drug Administration
D004043:Dietary Fiber; D004338:Drug Combinations; D005233:Fatty Alcohols; D005685:Galactans; D008351:Mannans; D053149:Plant Gums; D011663:Pulmonary Surfactants; D010767:Phosphorylcholine; D011092:Polyethylene Glycols; C047049:dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination; C007894:guar gum; D005283:Fentanyl